Hetastarch and Hydroxyethyl Starch Are Not the Same
Gregory A. Nuttall
Abstract
Gregory A. Nuttall
Abstract
In Response: I would like to thank Dr. Huettemann for his thoughtful letter to the editor. As noted by Treib et al. (1), there is only one type of hydroxyethyl starch available in the United States, whereas several hydroxyethyl starch preparations are widely used in Europe. The results of our study should only be applied to the preparation used in the United States (Hespan®, Abbott Laboratories, North Chicago, IL; average molecular weight 450,000 daltons, substitution of 0.7) or similar European preparations, because they induce a greater degree of anticoagulation than the smaller, more easily degraded hydroxyethyl starch preparations (1). Furthermore, as the anticoagulant effects of hydroxyethyl starch may potentiate the known coagulopathic state induced by cardiopulmonary bypass and exacerbate bleeding, the results of our study can only be applied to patients undergoing cardiopulmonary bypass. Gregory A. Nuttall MD
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In Response: I would like to thank Dr. Huettemann for his thoughtful letter to the editor. As noted by Treib et al. (1), there is only one type of hydroxyethyl starch available in the United States, whereas several hydroxyethyl starch preparations are widely used in Europe. The results of our study should only be applied to the preparation used in the United States (Hespan®, Abbott Laboratories, North Chicago, IL; average molecular weight 450,000 daltons, substitution of 0.7) or similar European preparations, because they induce a greater degree of anticoagulation than the smaller, more easily degraded hydroxyethyl starch preparations (1). Furthermore, as the anticoagulant effects of hydroxyethyl starch may potentiate the known coagulopathic state induced by cardiopulmonary bypass and exacerbate bleeding, the results of our study can only be applied to patients undergoing cardiopulmonary bypass. Gregory A. Nuttall MD
Key concepts: Hydroxyethyl starch, Hetastarch, Medicine, Cardiopulmonary bypass, Starch, Anesthesia, Biochemistry, Chemistry